Hims & Hers Health, Inc. - HIMS - Fundamentals

Best investment/trading ideas for the weekJoin our free webinar on May7,2026.

‌
‌

‌

Let's get started...

‌

Breakdown	2018 12/31	2019 12/31	2020 12/31	2021 12/31	2022 12/31	2023 12/31	2024 12/31	2025 12/31	TTM
REVENUE	27	83	149	272	527	872	1,477	2,348	2,348	📊
Revenue Growth (1Y)	--	+209.45%	+80.18%	+82.77%	+93.81%	+65.49%	+69.33%	+59.00%	--	📊
Revenue Growth (5Y)	--	--	--	--	+1875.02%	+956.23%	+892.57%	+763.49%	--	📊
Revenue Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Cost of Revenue	19	38	39	67	118	157	303	955	712	📊
Cost of Revenue Growth (1Y)	--	+101.06%	+3.57%	+71.43%	+75.40%	+32.88%	+93.17%	+214.86%	--	📊
Cost of Revenue Growth (5Y)	--	--	--	--	+526.16%	+313.80%	+671.82%	+1317.55%	--	📊
Cost of Revenue Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Gross Profit	8	45	109	204	409	715	1,173	1,392	1,635	📊
Gross Profit Growth (1Y)	--	+471.64%	+145.38%	+86.84%	+99.87%	+74.92%	+64.09%	+18.69%	--	📊
Gross Profit Growth (5Y)	--	--	--	--	+5138.01%	+1502.84%	+971.85%	+580.92%	--	📊
Gross Profit Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Operating Expenses	84	119	125	320	477	744	1,111	1,271	1,526	📊
Operating Expenses Growth (1Y)	--	+42.41%	+4.68%	+156.46%	+49.41%	+55.92%	+49.28%	+14.35%	--	📊
Operating Expenses Growth (5Y)	--	--	--	--	+471.25%	+525.45%	+791.88%	+297.68%	--	📊
Operating Expenses Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Sell General Administrative	84	119	113	250	371	576	847	1,121	1,170	📊
Research and Development	0	0	11	22	29	48	79	149	149	📊
Other Income Expenses	0	0	0	48	77	120	186	0	206	📊
EBITDA	0	-71	-14	-111	-61	-20	79	178	170	📊
EBITDA Growth (1Y)	--	--	+80.26%	-687.73%	+44.83%	+67.43%	+496.18%	+125.88%	--	📊
EBITDA Growth (5Y)	--	--	--	--	--	+72.05%	+660.74%	+260.79%	--	📊
EBITDA Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Depreciation and Amortization	76	0	1	4	7	10	17	55	55	📊
Operating Income	-76	-74	-15	-115	-69	-29	62	122	109	📊
Operating Income Growth (1Y)	--	+1.79%	+79.65%	-659.65%	+40.29%	+57.13%	+310.18%	+96.58%	--	📊
Operating Income Growth (5Y)	--	--	--	--	+9.33%	+60.42%	+508.76%	+205.78%	--	📊
Operating Income Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Interest Expense	0	0	0	0	0	0	0	0	--	📊
Pre Tax Income	-75	-72	-18	-111	-66	-22	72	124	124	📊
Tax Provision	0	0	0	-3	-0	2	-54	-4	-4	📊
NET INCOME	-75	-72	-18	-108	-66	-24	126	128	128	📊
Net Income Growth (1Y)	--	+4.22%	+74.86%	-494.34%	+38.99%	+64.15%	+635.28%	+1.85%	--	📊
Net Income Growth (5Y)	--	--	--	--	+12.71%	+67.33%	+795.80%	+219.23%	--	📊
Net Income Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Basic EPS	-1.12	-2.07	-0.51	-0.58	-0.32	-0.11	0.58	0.57	0.57	📊
Diluted EPS	-1.12	-2.07	-0.51	-0.58	-0.32	-0.11	0.53	0.51	0.51	📊
Basic Average Shares	67	35	35	187	205	209	216	225	225	📊
Diluted Average Shares	67	35	35	187	205	209	237	258	250	📊

Breakdown

2018

12/31

2019

12/31

2020

12/31

2021

12/31

2022

12/31

2023

12/31

2024

12/31

2025

12/31

TTM

REVENUE

149

272

527

872

1,477

2,348

📊

Revenue Growth (1Y)

+209.45%

+80.18%

+82.77%

+93.81%

+65.49%

+69.33%

+59.00%

📊

Revenue Growth (5Y)

+1875.02%

+956.23%

+892.57%

+763.49%

📊

Revenue Growth (10Y)

📊

Cost of Revenue

118

157

303

955

712

📊

Cost of Revenue Growth (1Y)

+101.06%

+3.57%

+71.43%

+75.40%

+32.88%

+93.17%

+214.86%

📊

Cost of Revenue Growth (5Y)

+526.16%

+313.80%

+671.82%

+1317.55%

📊

Cost of Revenue Growth (10Y)

📊

Gross Profit

109

204

409

715

1,173

1,392

1,635

📊

Gross Profit Growth (1Y)

+471.64%

+145.38%

+86.84%

+99.87%

+74.92%

+64.09%

+18.69%

📊

Gross Profit Growth (5Y)

+5138.01%

+1502.84%

+971.85%

+580.92%

📊

Gross Profit Growth (10Y)

📊

Operating Expenses

119

125

320

477

744

1,111

1,271

1,526

📊

Operating Expenses Growth (1Y)

+42.41%

+4.68%

+156.46%

+49.41%

+55.92%

+49.28%

+14.35%

📊

Operating Expenses Growth (5Y)

+471.25%

+525.45%

+791.88%

+297.68%

📊

Operating Expenses Growth (10Y)

📊

Sell General Administrative

119

113

250

371

576

847

1,121

1,170

📊

Research and Development

149

📊

Other Income Expenses

120

186

206

📊

EBITDA

-71

-14

-111

-61

-20

178

170

📊

EBITDA Growth (1Y)

+80.26%

-687.73%

+44.83%

+67.43%

+496.18%

+125.88%

📊

EBITDA Growth (5Y)

+72.05%

+660.74%

+260.79%

📊

EBITDA Growth (10Y)

📊

Depreciation and Amortization

📊

Operating Income

-76

-74

-15

-115

-69

-29

122

109

📊

Operating Income Growth (1Y)

+1.79%

+79.65%

-659.65%

+40.29%

+57.13%

+310.18%

+96.58%

📊

Operating Income Growth (5Y)

+9.33%

+60.42%

+508.76%

+205.78%

📊

Operating Income Growth (10Y)

📊

Interest Expense

📊

Pre Tax Income

-75

-72

-18

-111

-66

-22

124

📊

Tax Provision

-3

-0

-54

-4

📊

NET INCOME

-75

-72

-18

-108

-66

-24

126

128

📊

Net Income Growth (1Y)

+4.22%

+74.86%

-494.34%

+38.99%

+64.15%

+635.28%

+1.85%

📊

Net Income Growth (5Y)

+12.71%

+67.33%

+795.80%

+219.23%

📊

Net Income Growth (10Y)

📊

Basic EPS

-1.12

-2.07

-0.51

-0.58

-0.32

-0.11

0.58

0.57

📊

Diluted EPS

-1.12

-2.07

-0.51

-0.58

-0.32

-0.11

0.53

0.51

📊

Basic Average Shares

187

205

209

216

225

📊

Diluted Average Shares

187

205

209

237

258

250

📊

Ex-Dividend date	--
Payment date	--
Annual Dividend	--
Dividend Yield	--
Shareholders Yield	-16.15%
Next Earnings	05/11/2026
Market cap	6.17B (USD)
EPS (TTM)	0.57 ($)
P/E (TTM)	47.67 ($)
Last Close	27.17

Next Earnings	05/11/2026
Market cap	6.17B (USD)
EPS (TTM)	0.57 ($)
P/E (TTM)	47.67 ($)
Last Close	27.17 ($)

Ex-Dividend date	--
Payment date	--
Annual Dividend	--
Dividend Yield	--
Shareholders Yield	-16.15%
Next Earnings	05/11/2026
Market cap	6.17B (USD)
EPS (TTM)	0.57 ($)
P/E (TTM)	47.67 ($)
Last Close	27.17

Next Earnings	05/11/2026
Market cap	6.17B (USD)
EPS (TTM)	0.57 ($)
P/E (TTM)	47.67 ($)
Last Close	27.17 ($)